Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 1, 1996
Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 7. Fluoride therapy for osteoporosisT M Murray, L G Ste-MarieOsteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 16, 2020
Upper gastrointestinal safety of oral bisphosphonate in hospitalized patientsP V-Q Nguyen, M Bouin, L G Ste-MarieCalcified Tissue International|October 13, 2004
Five years of treatment with risedronate and its effects on bone safety in women with postmenopausal osteoporosisL-G Ste-Marie, E Sod, T Johnson, et al.The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|December 28, 2002
Quantitative immunogold labeling of bone sialoprotein and osteopontin in methylmethacrylate-embedded rat boneO Laboux, L-G Ste-Marie, F H Glorieux, et al.Calcified Tissue International|January 3, 2001
Longitudinal study of bone density and its determinants in women in peri- or early menopauseD Picard, A Imbach, M Couturier, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 13, 2014
The impact of educational interventions on modifiable risk factors for osteoporosis after a fragility fractureC Beaudoin, L Bessette, S Jean, et al.Journal of Clinical Pathology|October 1, 1984
Iliac bone histomorphometry in adults and children with osteogenesis imperfectaL G Ste-Marie, S A Charhon, C Edouard, et al.Clinical Endocrinology|July 17, 1998
Functional evidence for two types of parathyroid adenomaP D'Amour, J Weisnagel, J H Brossard, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 25, 2008
Comparison of direct health care costs related to the pharmacological treatment of osteoporosis and to the management of osteoporotic fractures among compliant and noncompliant users of alendronate and risedronate: a population-based studyJ Blouin, A Dragomir, M Fredette, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|April 28, 2016
Denosumab compared to other treatments to prevent or treat osteoporosis in individuals at risk of fracture: a systematic review and meta-analysisC Beaudoin, S Jean, L Bessette, et al.Pageof 4